Back to Journals » HIV/AIDS - Research and Palliative Care » Call For Papers
HIV/AIDS - Research and Palliative Care
The following Article Collection/ Thematic Series is currently open for submissions:
We are pleased to announce a new Article Collection in HIV/AIDS - Research and Palliative Care, dedicated to the transformative role of pre-exposure prophylaxis (PrEP) in HIV prevention. Since its clinical introduction, PrEP has revolutionized HIV care, providing significant benefits in preventing transmission, enhancing prevention confidence, and reducing anxiety for at-risk populations.
Given the global importance of PrEP, HIV/AIDS - Research and Palliative Care invites submissions of original research articles, reviews, and perspectives exploring the clinical efficacy, safety, mechanisms of action, and real-world application of this transformative strategy.
The collection, edited by Editor-In-Chief Professor Olubunmi Akindele Ogunrin, will be included in Taylor & Francis’ Game Changer Series. This series features Article Collections focused on breakthrough therapies, drugs, or technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.
Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.
While the call is open to receive manuscripts across the broad spectrum of PrEP in HIV prevention, the Editors are particularly interested in manuscripts relating to the following areas:
- Agents in PrEP strategy
- Delivery models
- Target populations
- Barriers and support
- Education, acceptability, adoption, adherence and retention
All manuscripts submitted to this Article Collection will undergo a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 1 April 2026.
Please submit your manuscript on our website. Submitting authors are eligible for a 20% discount on the Article Publishing charge by applying the following code at the point of submission F4375.
If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor at [email protected].
Guest Advisors
Olubunmi Akindele Ogunrin, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom
Call For Papers
Editor-in-Chief: Prof. Dr. Ogunrin
To see where HIV/AIDS - Research and Palliative Care is indexed online view the Journal Metrics.
What is the advantage to you of publishing in HIV/AIDS - Research and Palliative Care?
- It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
- Unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
- The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. HIV/AIDS - Research and Palliative Care has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
- Many authors have found that our peer reviewer’s comments substantially add to their final papers.
To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.
PubMed Central
HIV/AIDS - Research and Palliative Care is indexed on PubMed Central (title abbreviation: (HIV AIDS (Auckl)). All published papers in this journal are submitted to PubMed for indexing straight away.
Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.
Yours sincerely
Prof. Dr. Ogunrin
Editor-in-Chief
HIV/AIDS - Research and Palliative Care
Email: Editor-in-Chief
Updated 11 October 2022